ZYBT Zhengye Biotechnology Holding Limited
Fundamentals / CIK 0001975641 / CNYZhengye Biotechnology Holding Limited reported ¥116.4M in revenue and a net loss of ¥69.78M for the fiscal year ended December 31, 2025 (down 37.6% year over year), with a 20.5% gross margin and a -60.6% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ZYBT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025¥116.4M -37.6% YoY
-
Operating Income FY 2025-¥70.51M -60.6% margin
-
Net Income FY 2025-¥69.78M -60.0% net margin
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025¥12.32M 10.6% FCF margin
-
Cash & ST Investments Dec 31, 2025¥51.89M Total debt: ¥75.08M
Annual revenue and net income
4 fiscal years (2022 to 2025), reported in CNY.
Financial statements and ratios
Reported in CNY. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in CNY · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Revenue | ¥116.4M | ¥186.4M | ¥211.7M | ¥260.3M |
| Cost of Revenue | ¥92.49M | ¥95.06M | ¥94.14M | ¥112.4M |
| Gross Profit | ¥23.87M | ¥91.30M | ¥117.5M | ¥147.9M |
| Research & Development | ¥18.01M | ¥12.79M | ¥11.90M | ¥13.42M |
| Selling, General & Admin | ¥74.92M | ¥63.84M | ¥64.33M | ¥58.89M |
| Total Operating Expenses | ¥94.38M | ¥74.86M | ¥72.52M | ¥82.05M |
| Operating Income | -¥70.51M | ¥16.44M | ¥44.99M | ¥65.83M |
| EBITDA | -¥44.62M | ¥40.60M | ¥68.90M | ¥84.63M |
| Interest Income | ¥96K | ¥231K | ¥312K | ¥114K |
| Interest Expense | ¥3.40M | ¥4.04M | ¥4.42M | ¥2.84M |
| Income Before Tax | -¥71.87M | ¥14.39M | ¥43.76M | ¥63.91M |
| Income Tax Expense | ¥11.10M | ¥924K | ¥6.25M | ¥8.17M |
| Net Income | -¥69.78M | ¥11.31M | ¥31.46M | ¥46.73M |
| Basic EPS | -- | ¥0.25 | ¥0.69 | ¥1.02 |
| Diluted EPS | -- | ¥0.25 | ¥0.69 | ¥1.02 |
| Basic Shares Outstanding | 47.3M | 45.7M | 45.7M | 45.7M |
| Diluted Shares Outstanding | 47.3M | 45.7M | 45.7M | 45.7M |
Income Statement (Quarterly) · Reported in CNY · Newest filing period first.
Balance Sheet (Annual) · Reported in CNY · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | ¥50.33M | ¥18.60M | ¥15.07M |
| Short-Term Investments | ¥1.56M | ¥1.43M | ¥1.22M |
| Cash & Short-Term Investments | ¥51.89M | ¥20.04M | ¥16.30M |
| Accounts Receivable, Net | ¥18.48M | ¥59.56M | ¥74.17M |
| Inventory | ¥39.17M | ¥58.22M | ¥58.30M |
| Total Current Assets | ¥137.4M | ¥177.6M | ¥189.2M |
| Property, Plant & Equipment, Net | ¥236.8M | ¥255.2M | ¥263.2M |
| Intangible Assets | ¥47.08M | ¥14.85M | ¥16.30M |
| Total Non-Current Assets | ¥299.1M | ¥315.7M | ¥310.6M |
| Total Assets | ¥436.5M | ¥493.2M | ¥499.9M |
| Accounts Payable | ¥44.01M | ¥42.96M | ¥45.66M |
| Short-Term Debt | ¥65.80M | ¥81.63M | ¥79.86M |
| Deferred Revenue (Current) | ¥4.75M | ¥3.48M | ¥3.88M |
| Total Current Liabilities | ¥120.5M | ¥135.9M | ¥150.2M |
| Long-Term Debt | ¥8.85M | ¥4.80M | ¥9.99M |
| Total Non-Current Liabilities | ¥9.28M | ¥4.80M | ¥10.38M |
| Total Liabilities | ¥129.8M | ¥140.7M | ¥160.6M |
| Total Debt (incl. Leases) | ¥75.08M | ¥86.43M | ¥89.85M |
| Common Stock | -- | ¥8.0K | ¥8.0K |
| Retained Earnings | -¥21.63M | ¥48.15M | ¥38.38M |
| Accumulated Other Comp. Income | -¥1.93M | ¥3.0K | -- |
| Total Stockholders' Equity | ¥249.8M | ¥284.0M | ¥272.9M |
| Total Equity | ¥306.7M | ¥352.5M | ¥339.3M |
Balance Sheet (Quarterly) · Reported in CNY · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash & Cash Equivalents | ¥50.33M | ¥18.60M | ¥15.07M |
| Short-Term Investments | ¥1.56M | ¥1.43M | ¥1.22M |
| Cash & Short-Term Investments | ¥51.89M | ¥20.04M | ¥16.30M |
| Accounts Receivable, Net | ¥18.48M | ¥59.56M | ¥74.17M |
| Inventory | ¥39.17M | ¥58.22M | ¥58.30M |
| Total Current Assets | ¥137.4M | ¥177.6M | ¥189.2M |
| Property, Plant & Equipment, Net | ¥236.8M | ¥255.2M | ¥263.2M |
| Intangible Assets | ¥47.08M | ¥14.85M | ¥16.30M |
| Total Non-Current Assets | ¥299.1M | ¥315.7M | ¥310.6M |
| Total Assets | ¥436.5M | ¥493.2M | ¥499.9M |
| Accounts Payable | ¥44.01M | ¥42.96M | ¥45.66M |
| Short-Term Debt | ¥65.80M | ¥81.63M | ¥79.86M |
| Deferred Revenue (Current) | ¥4.75M | ¥3.48M | ¥3.88M |
| Total Current Liabilities | ¥120.5M | ¥135.9M | ¥150.2M |
| Long-Term Debt | ¥8.85M | ¥4.80M | ¥9.99M |
| Total Non-Current Liabilities | ¥9.28M | ¥4.80M | ¥10.38M |
| Total Liabilities | ¥129.8M | ¥140.7M | ¥160.6M |
| Total Debt (incl. Leases) | ¥75.08M | ¥86.43M | ¥89.85M |
| Common Stock | -- | ¥8.0K | ¥8.0K |
| Retained Earnings | -¥21.63M | ¥48.15M | ¥38.38M |
| Accumulated Other Comp. Income | -¥1.93M | ¥3.0K | -- |
| Total Stockholders' Equity | ¥249.8M | ¥284.0M | ¥272.9M |
| Total Equity | ¥306.7M | ¥352.5M | ¥339.3M |
Cash Flow Statement (Annual) · Reported in CNY · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Net Income | -¥82.97M | ¥13.47M | ¥37.51M | ¥55.74M |
| Depreciation & Amortization | ¥25.88M | ¥24.16M | ¥23.91M | ¥18.80M |
| Change in Receivables | ¥39.71M | ¥16.34M | ¥31.04M | -¥24.96M |
| Change in Inventory | ¥6.25M | -¥5.88M | -¥12.90M | -¥12.32M |
| Change in Payables | -¥3.36M | -¥404K | -¥35.61M | -¥9.67M |
| Operating Cash Flow | ¥13.33M | ¥41.05M | ¥48.18M | ¥17.34M |
| Capital Expenditure | -¥1.01M | -¥13.59M | -¥7.40M | -¥27.33M |
| Free Cash Flow | ¥12.32M | ¥27.46M | ¥40.79M | -¥9.99M |
| Investing Cash Flow | -¥12.63M | -¥27.66M | -¥11.77M | -¥27.33M |
| Dividends Paid | -- | -¥16.02M | -¥39.45M | -¥21.43M |
| Financing Cash Flow | ¥32.31M | -¥22.13M | -¥18.98M | ¥13.46M |
| Net Change in Cash | ¥31.73M | -¥8.58M | ¥17.44M | ¥3.46M |
Cash Flow Statement (Quarterly) · Reported in CNY · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Gross Margin | 20.5% | 49.0% | 55.5% | 56.8% |
| Operating Margin | -60.6% | 8.8% | 21.3% | 25.3% |
| Net Profit Margin | -60.0% | 6.1% | 14.9% | 18.0% |
| Return on Equity (ROE) | -27.9% | 4.0% | 11.5% | -- |
| Return on Assets (ROA) | -16.0% | 2.3% | 6.3% | -- |
| Current Ratio | 1.14x | 1.31x | 1.26x | -- |
| Quick Ratio | 0.82x | 0.88x | 0.87x | -- |
| Debt to Equity | 0.30x | 0.30x | 0.33x | -- |
| Revenue Growth (YoY) | -37.6% | -12.0% | -18.7% | -- |
| Gross Profit Growth (YoY) | -73.9% | -22.3% | -20.5% | -- |
| Operating Income Growth (YoY) | -528.9% | -63.5% | -31.7% | -- |
| Net Income Growth (YoY) | -717.0% | -64.0% | -32.7% | -- |
| EPS Growth (YoY) | -- | -63.8% | -32.4% | -- |
| Operating Cash Flow Growth (YoY) | -67.5% | -14.8% | +178.0% | -- |
| Free Cash Flow Growth (YoY) | -55.1% | -32.7% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.